|
Natalie Cole Optimistic About Her Battle with Hepatitis C
Although currently recovering from combination therapy's side effects, the well-respected vocalist Natalie Cole may have conquered the Hepatitis C virus....
Hep C and Fatty Liver Disease Linked
Pittsburgh researchers have found an enzyme known to participate in fat production is elevated in those with Hepatitis C. Further exploration of this enzyme could help physicians better predict which HCV patients are at risk of developing fatty liver disease....
Anadys' ANA773 Hepatitis C Phase I Trials in Netherlands
Reducing the dosing schedule in half, Anadys Pharmaceuticals continues its investigation of ANA773, a Toll-Like Receptor-7 agonist prodrug. Approaching the Hepatitis C virus differently from most other contenders, Phase I clinical trials evaluating the safety, tolerability and viral-load decline associated...
|
|
|
Effects of Propranolol on the Hepatic Hemodynamic Response to Physical Exercise
in Patients With Cirrhosis
| table 2. Splanchnic Hemodynamics in
Baseline Conditions, After Placebo or Propranolol Administration,
During Exercise and 30 Minutes After Recovery Period |
|
|
Placebo or Propranolol
Infusion
|
| Baseline |
Pre-exercise |
Exercise |
Recovery |
ANOVA |
|
| HVPG (mm Hg) |
|
|
|
|
| Placebo |
16.9 ± 0.9 |
16.7 ± 0.9 |
19.0 ± 1.0 |
16.7 ± 0.8 |
0.04 |
| Propranolol |
19.3 ± 1.1 |
16.3 ± 1.0* |
12.9 ± 1.1*,  |
16.9 ± 1.2* |
0.002 |
HBF (mL · min 1) |
|
| Placebo |
1,074 ± 119 |
990 ± 141 |
810 ± 72* |
843 ± 82 |
0.05 |
| Propranolol |
1,366 ± 123 |
978 ± 104* |
724 ± 79*,  |
926 ± 91* |
0.001 |
EHVR (dyn · s · cm 5) |
| Placebo |
1,320 ± 107 |
1,481 ± 172 |
1,895 ± 116*,  |
1,612 ± 125 |
0.03 |
| Propranolol |
1,191 ± 131 |
1,433 ± 151 |
1,623 ± 178 |
1,444 ± 109 |
ns |
AzBF (mL · min 1)§ |
| Placebo |
537 ± 64 |
522 ± 75 |
547 ± 70 |
504 ± 54 |
ns |
| Propranolol |
722 ± 117 |
396 ± 64* |
398 ± 42* |
383 ± 59* |
0.02 |
|
NOTE. Data are shown as means ± SEM.
Abbreviations: EHVR, estimated hepatic vascular resistance; ns, not
significant.
* P < .05 vs.
baseline.
P < .05 vs. pre-exercise.
Measured in 10 patients
in each group.
§ Measured in 6 patients
in each group. |
|
Return To Article
|
|